United States · Bill · HR
H.R. 2700 (108th)
Medicare Patient Access to Drugs for Rare Diseases Act of 2003
Introduced
10 July 2003
Last action
23 July 2003 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Cox, Christopher [R-CA-48], Rep. Norwood, Charles W. [R-GA-9], Rep. Issa, Darrell [R-CA-48], Rep. Engel, Eliot L. [D-NY-16], Rep. Boucher, Rick [D-VA-9], Rep. Berman, Howard L. [D-CA-28], Rep. Pomeroy, Earl [D-ND-At Large], Rep. McDermott, Jim [D-WA-7], Rep. Shimkus, John [R-IL-15], Rep. Rush, Bobby L. [D-IL-1], Rep. Lantos, Tom [D-CA-12], Del. Christensen, Donna M. [D-VI-At Large], Rep. Bono, Mary [R-CA-44], Rep. Napolitano, Grace F. [D-CA-32], Rep. Rogers, Mike J. [R-MI-8], Rep. Barton, Joe [R-TX-6], Rep. Rohrabacher, Dana [R-CA-48], Rep. Eshoo, Anna G. [D-CA-18], Rep. Sanchez, Loretta [D-CA-46], Rep. Calvert, Ken [R-CA-41], Rep. Pallone, Frank [D-NJ-6], Rep. Dreier, David [R-CA-26], Rep. Hoeffel, Joseph M. [D-PA-13], Rescom. Acevedo-Vila, Anibal [D-PR-At Large], Rep. Allen, Thomas H. [D-ME-1], Rep. Price, David E. [D-NC-4], Rep. Lynch, Stephen F. [D-MA-8], Rep. Emanuel, Rahm [D-IL-5], Rep. Terry, Lee [R-NE-2], Rep. Frank, Barney [D-MA-4], Rep. Kind, Ron [D-WI-3], Rep. Grijalva, Raúl M. [D-AZ-7], Rep. Sánchez, Linda T. [D-CA-38], Rep. Millender-McDonald, Juanita [D-CA-37]
Subjects
Healthcare
Source updated
18 August 2025
Summary
Medicare Patient Access to Drugs for Rare Diseases Act of 2003 - Amends title XVIII (Medicare) of the Social Security Act to revise the methodology by which payment for orphan drugs and biologicals is made under the Medicare prospective payment system for hospital outpatient department (OPD) services. Directs the Secretary to report to specified congressional committees on payment for orphan drugs and biologicals and blood clotting factors for individuals with hemophilia in the OPD setting, including recommendations for either continuing or discontinuing the exclusion of such drugs and biologicals from payment under Medicare. Provides for a moratorium on decreases in payment rates for orphan drugs and biologicals and blood clotting factors for certain individuals with hemophilia.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
10 July 2003
Introduced
Introduced in House
Source: IntroReferral
10 July 2003
Introduced
Introduced in House
Source: IntroReferral
10 July 2003
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
10 July 2003
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
22 July 2003
Referred
Referred to the Subcommittee on Health.
Source: Committee
23 July 2003
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 10 July 2003 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 10 July 2003
Introduced in House (PDF)
Introduced in House · EN · 10 July 2003
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 10 July 2003
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Cox, Christopher [R-CA-48] · R · Sponsor
- Rep. Norwood, Charles W. [R-GA-9] · R · Sponsor
- Rep. Issa, Darrell [R-CA-48] · R · Sponsor
- Rep. Engel, Eliot L. [D-NY-16] · D · Sponsor
- Rep. Boucher, Rick [D-VA-9] · D · Sponsor
- Rep. Berman, Howard L. [D-CA-28] · D · Sponsor
- Rep. Pomeroy, Earl [D-ND-At Large] · D · Sponsor
- Rep. McDermott, Jim [D-WA-7] · D · Cosponsor
- Rep. Shimkus, John [R-IL-15] · R · Cosponsor
- Rep. Rush, Bobby L. [D-IL-1] · D · Cosponsor
- Rep. Lantos, Tom [D-CA-12] · D · Cosponsor
- Del. Christensen, Donna M. [D-VI-At Large] · D · Cosponsor
- Rep. Bono, Mary [R-CA-44] · R · Cosponsor
- Rep. Napolitano, Grace F. [D-CA-32] · D · Cosponsor
- Rep. Rogers, Mike J. [R-MI-8] · R · Cosponsor
- Rep. Barton, Joe [R-TX-6] · R · Cosponsor
- Rep. Rohrabacher, Dana [R-CA-48] · R · Cosponsor
- Rep. Eshoo, Anna G. [D-CA-18] · D · Cosponsor
- Rep. Sanchez, Loretta [D-CA-46] · D · Cosponsor
- Rep. Calvert, Ken [R-CA-41] · R · Cosponsor
- Rep. Pallone, Frank [D-NJ-6] · D · Cosponsor
- Rep. Dreier, David [R-CA-26] · R · Cosponsor
- Rep. Hoeffel, Joseph M. [D-PA-13] · D · Cosponsor
- Rescom. Acevedo-Vila, Anibal [D-PR-At Large] · D · Cosponsor
- Rep. Allen, Thomas H. [D-ME-1] · D · Cosponsor
- Rep. Price, David E. [D-NC-4] · D · Cosponsor
- Rep. Lynch, Stephen F. [D-MA-8] · D · Cosponsor
- Rep. Emanuel, Rahm [D-IL-5] · D · Cosponsor
- Rep. Terry, Lee [R-NE-2] · R · Cosponsor
- Rep. Frank, Barney [D-MA-4] · D · Cosponsor
- Rep. Kind, Ron [D-WI-3] · D · Cosponsor
- Rep. Grijalva, Raúl M. [D-AZ-7] · D · Cosponsor
- Rep. Sánchez, Linda T. [D-CA-38] · D · Cosponsor
- Rep. Millender-McDonald, Juanita [D-CA-37] · D · Cosponsor
- · hsif00 · Standing
- · hswm00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/108th-congress/house-bill/2700
- Open data entity: https://api.congress.gov/v3/bill/108/hr/2700
- us · 108-hr-2700 · source updated 18 August 2025